33 related articles for article (PubMed ID: 38646500)
1. Tumor‑suppressive effects of Smad‑ubiquitination regulator 2 in papillary thyroid carcinoma.
Luo G; Zhang L; Zhang L; Wu W; Lin J; Shi H; Yu Y; Qiu W; Chen J; Ding H; Chen X
Oncol Lett; 2024 Jun; 27(6):263. PubMed ID: 38646500
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of ubiquitin carboxy‑terminal hydrolase 47 (USP47) in papillary thyroid carcinoma ex vivo and reduction of tumor cell malignant behaviors after USP47 knockdown by stabilizing SATB1 expression in vitro.
Luo G; Zhang L; Wu W; Zhang L; Lin J; Shi H; Wu X; Yu Y; Qiu W; Chen J; Ding H; Chen X
Oncol Lett; 2023 Sep; 26(3):370. PubMed ID: 37564825
[TBL] [Abstract][Full Text] [Related]
3. The ubiquitination ligase SMURF2 reduces aerobic glycolysis and colorectal cancer cell proliferation by promoting ChREBP ubiquitination and degradation.
Li Y; Yang D; Tian N; Zhang P; Zhu Y; Meng J; Feng M; Lu Y; Liu Q; Tong L; Hu L; Zhang L; Yang JY; Wu L; Tong X
J Biol Chem; 2019 Oct; 294(40):14745-14756. PubMed ID: 31409643
[TBL] [Abstract][Full Text] [Related]
4. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
[TBL] [Abstract][Full Text] [Related]
5. LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma.
Zhao S; Wang Q; Li Z; Ma X; Wu L; Ji H; Qin G
J Exp Clin Cancer Res; 2015 Dec; 34():146. PubMed ID: 26637328
[TBL] [Abstract][Full Text] [Related]
6. LncRNA RGMB-AS1 is activated by E2F1 and promotes cell proliferation and invasion in papillary thyroid carcinoma.
Zhang Z; Li SY; Zhang LB
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1979-1986. PubMed ID: 29687852
[TBL] [Abstract][Full Text] [Related]
7. [Changes and Perspectives in the New 2022 WHO Classification of Thyroid Neoplasms].
Cameselle-Teijeiro JM
Rev Esp Patol; 2022; 55(3):145-148. PubMed ID: 35779879
[No Abstract] [Full Text] [Related]
8. Smurf2 inhibition enhances chemotherapy and radiation sensitivity in non-small-cell lung cancer.
Chaudhary KR; Kinslow CJ; Cheng H; Silva JM; Yu J; Wang TJ; Hei TK; Halmos B; Cheng SK
Sci Rep; 2022 Jun; 12(1):10140. PubMed ID: 35710591
[TBL] [Abstract][Full Text] [Related]
9. Smurf2 suppresses the metastasis of hepatocellular carcinoma via ubiquitin degradation of Smad2.
Song D; Li S; Ning L; Zhang S; Cai Y
Open Med (Wars); 2022; 17(1):384-396. PubMed ID: 35509688
[TBL] [Abstract][Full Text] [Related]
10. Single-cell transcriptomic analysis of the tumor ecosystems underlying initiation and progression of papillary thyroid carcinoma.
Pu W; Shi X; Yu P; Zhang M; Liu Z; Tan L; Han P; Wang Y; Ji D; Gan H; Wei W; Lu Z; Qu N; Hu J; Hu X; Luo Z; Li H; Ji Q; Wang J; Zhang X; Wang YL
Nat Commun; 2021 Oct; 12(1):6058. PubMed ID: 34663816
[TBL] [Abstract][Full Text] [Related]
11. E3 ubiquitin ligase SMURF2 prevents colorectal cancer by reducing the stability of the YY1 protein and inhibiting the SENP1/c-myc axis.
Gao Q; Wang S; Zhang Z
Gene Ther; 2023 Feb; 30(1-2):51-63. PubMed ID: 34545207
[TBL] [Abstract][Full Text] [Related]
12. Integrating metabolic reprogramming and metabolic imaging to predict breast cancer therapeutic responses.
Liu Y; Zhou Q; Song S; Tang S
Trends Endocrinol Metab; 2021 Oct; 32(10):762-775. PubMed ID: 34340886
[TBL] [Abstract][Full Text] [Related]
13. SMURF2-mediated ubiquitin signaling plays an essential role in the regulation of PARP1 PARylating activity, molecular interactions, and functions in mammalian cells.
Ilić N; Tao Y; Boutros-Suleiman S; Kadali VN; Emanuelli A; Levy-Cohen G; Blank M
FASEB J; 2021 Apr; 35(4):e21436. PubMed ID: 33734501
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]